Advertisement

Topics

Latest Cancer NewsRSS

14:09 EST 15th December 2018 | BioPortfolio

IV Diagnostics Inc Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryIV Diagnostics Inc IV Diagnostics is a biomedical company that offers research services. The company conducts molecular diagnostic tests for circulating tumor cells and other blood borne diseases. It develops, tests and markets diagnostic tools that monitor and measure cancer tumor cells. IV Diagnostics' products include Velox, MagnoPraxis and Admonitrix. The company's Velox is used in trea...

The Wistar Institute Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryThe Wistar Institute Wistar is a biomedical research institute that carries out medical research and training. The institute performs research in the areas of cancer, infectious diseases, immunology and vaccine development. It also conducts research on genes, gene expression, and DNA biology; cancer biology; translational research; and virology. Wistar develops vaccines against rotavirus, r...

Opinion: "Be better than your brain. If you love someone, get a flu shot." https://buff.ly/2Lkq46i 

Opinion: "Be better than your brain. If you love someone, get a flu shot." https://buff.ly/2Lkq46i 

New #Cancer Drug Saves Teen's Life $LOXO https://www.nbcdfw.com/news/local/New-Cancer-Drug-Saves-Teens-Life-502818421.html …

New #Cancer Drug Saves Teen's Life $LOXO https://www.nbcdfw.com/news/local/New-Cancer-Drug-Saves-Teens-Life-502818421.html …

Verisante Technology Inc Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryVerisante Technology Inc Verisante is a medical device company that develops and commercializes systems for the early detection of cancer. The company's key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for lung, colon and cervical cancer detection. Verisante MSI Camera is a...

GeneNews Ltd GEN Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryGeneNews Ltd GeneNews is a provider of molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of body state using blood. GeneNews offers biomarkers for detect disease, stage diseases, monitor and progression and determine treatment...

Lethal combination: Drug cocktail turns off the juice to cancer cells https://www.unibas.ch/en/News-Events/News/Uni-Research/Drug-cocktail-turns-off-the-juice-to-cancer-cells.html …

Lethal combination: Drug cocktail turns off the juice to cancer cells https://www.unibas.ch/en/News-Events/News/Uni-Research/Drug-cocktail-turns-off-the-juice-to-cancer-cells.html …

Celltrion, $TEVA; FDA Approval of HERZUMA® a Biosimilar to HERCEPTIN®, for the Treatment of HER2-Overexpressing Breast Cancer for Certain Indications https://www.businesswire.com/news/home/20181214005566/en/Celltrion-Teva-Announce-FDA-Approval-HERZUMA%C

Celltrion, $TEVA; FDA Approval of HERZUMA® a Biosimilar to HERCEPTIN®, for the Treatment of HER2-Overexpressing Breast Cancer for Certain Indications https://www.businesswire.com/news/home/20181214005566/en/Celltrion-Teva-Announce-FDA-Approval-HERZUMA%C2%AE-trastuzumab-pkrb …

$BGNE Updated Phase 1A/1B Data on Tislelizumab Presented at #ESMO18 https://globenewswire.com/news-release/2018/12/15/1667574/0/en/BeiGene-Announces-Updated-Phase-1A-1B-Data-on-Tislelizumab-Presented-at-the-European-Society-for-Medical-Oncology-Immuno-Onc

$BGNE Updated Phase 1A/1B Data on Tislelizumab Presented at #ESMO18 https://globenewswire.com/news-release/2018/12/15/1667574/0/en/BeiGene-Announces-Updated-Phase-1A-1B-Data-on-Tislelizumab-Presented-at-the-European-Society-for-Medical-Oncology-Immuno-Oncology-Congress.html …

Sorrento Therapeutics Inc SRNE Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummarySorrento Therapeutics Inc STI, formerly QuikByte Software Inc, is a cancer therapeutic service provider. The company offers CD38 CART, lidocaine topical system, resiniferatoxin. Its product pipeline includes CD38 CART, CEA CART, CD38 ADC and seprehvir. STI provides treatment for multiple myeloma, metastatic liver tumors and solid tumors. The company offers therapies for immune oncology, pai...

BeiGene Announces Updated Phase 1A/1B Data on Tislelizumab Presented at the European Society for Medical Oncology Immuno-Oncology Congress

CAMBRIDGE, Mass. and BEIJING, China, Dec. 15, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, announced that updated clinical data from an ongoing Phase 1A/1B trial of tislelizumab, an investigational an...

Celltrion and Teva Announce FDA Approval of HERZUMA® (trastuzumab-pkrb), a Biosimilar to HERCEPTIN®, for the Treatment of HER2-Overexpressing Breast Cancer for Certain Indications

Celltrion, Inc. (KRX:068270) and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved HERZUMA

Risk for Esophageal Cancer in Patients with Gastroesophageal Reflux

Risk decreases over time with antireflux surgery or medication.

Research model relates variations in #DNA and gene activity to the risk of brain disorders: http://ow.ly/neer30mZrGK 

Research model relates variations in #DNA and gene activity to the risk of brain disorders: http://ow.ly/neer30mZrGK 

Systems Oncology Announces Pipeline of Innovative Drugs Emerging from the Use of Artificial Intelligence

Dr. Spyro Mousses, CEO of Systems Oncology, LLC, announced Systems Oncology’s diversified pipeline of innovative oncology programs discovered with the help of Artificial Intelligence at the AIMed North America Conference in Dana Point, California. Systems Oncology, an AI-based biopharmaceutical company, utilizes computational tools and machine l...

Biosimilar Approved By FDA For Treating HER2-overexpressing Breast Cancer

The FDA has approved trastuzumab-pkrb (Herzuma, Celltrion) as a biosimilar to trastuzumab (Herceptin, Genentech) for the treatment of HER2-overexpressing breast cancer. 

Pulse Biosciences, Inc. Announces Closing of Its $45 Million Rights Offering

Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse Biosciences” or the “Company”), a novel medical therapy company bringing to market its proprietary CellFX™ Nano-Pulse Stimulation™ (NPS™) platform, announced today that its rights offering has closed. The rights offering resulted in the issuance of 3,581,148 shares of the Company’s com...

Chemical Biologists Unearth Cause of Rare Brain Disorder

NewsResearchers have keyed into the biological mishap that causes stunted brain growth and muscle movement failure.

Cascadian Therapeutics Inc CASC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryCascadian Therapeutics Inc Cascadian, formerly Oncothyreon Inc is a clinicalstage biotechnology company that develops therapeutic products for the treatment of cancer. The company's lead clinicalstage product candidate includes ONT380, an orally active and selective smallmolecule HER2 inhibitor which is intended for the treatment of HER2positive HER2+ metastatic breast cancer. It also devel...

Does Prophylactic Salpingo-Oophorectomy Also Reduce Risk for Breast Cancer?

Time-dependent analysis confirms that the answer is no.

Brain MRI research fuels hopes for an answer to Alzheimer’s

Tens of millions of baby boomers are expected to live long enough to develop Alzheimer’s, and just about as many are worried about those prospects. One of them is a writer on Cape Cod named Susan Moeller. A recent memory lapse prompted her to publish her hopes, fears and observations.

Does dark matter really cause skin cancer? Have a guess.

A far-out theory proposed earlier this year falls apart under closer examination, says a new study.

Prestige BioPharma Partners with Cipla to Market Key Cancer Biosimilar

NewsThe licensing agreement for the HD20 trastuzumab biosimilar gives Cipla Ltd. exclusive rights to distribute and market the drug in selected emerging markets.

Trastuzumab Biosimilar CT-P6 Shows Comparable Efficacy at 2-Year Follow-up

CT-P6, a proposed biosimilar to trastuzumab, exhibited long-term disease-free survival and overall survival similar to the reference product in the treatment of patients with HER2-positive early breast cancer.

Terumo Corporation Strategy, SWOT and Corporate Finance Report [Report Updated: 26112018] Prices from USD $175

Terumo Corporation Strategy, SWOT and Corporate Finance ReportSummaryTerumo Corporation Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsTerumo Corporation Terumo or 'the ...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Cancer market research data and corporate reports here